Call to make take-home naloxone more accessible

The recent down-scheduling of naloxone to Schedule 3 must be followed up by regulatory changes that allow take-home programs to dispense the drug directly to their clients, without the need for pharmacist or doctor involvement, say addiction experts.

While OTC access removes the need for a doctor’s prescription, the requirement for dispensing by a doctor or pharmacist remains, they writes in the Medical Journal of Australia.